1.2140
-0.0140
(-1.14%)
As of 12:50:28 PM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Albert Alexander Haeggstrom | CFO & Director | 45.01k | -- | 1971 |
| Prof. Edward Olof Haeggstrom | Co-Founder & CEO | -- | -- | 1969 |
| Mr. Henri von Haartman | Director of Investor Relations | -- | -- | -- |
| Mr. Peter Hanninen | General Counsel & Chief Development Officer | -- | -- | 1988 |
| Dr. David Rowe | Head of Manufacturing | -- | -- | 1967 |
| Mr. Christian Jones | Chief Commercial Officer | -- | -- | 1980 |
| Mr. Antonio Da Silva | Chief of Business Operations | -- | -- | 1974 |
| Ms. Johanna Kause | Chief Quality Officer | -- | -- | 1971 |
| Dr. Jamie Unwin | Vice President of Strategic Insight | -- | -- | -- |
Nanoform Finland Oyj
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 174
Description
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquartered in Helsinki, Finland.
Corporate Governance
Nanoform Finland Oyj’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 27, 2025 at 6:10 AM UTC
Nanoform Finland Oyj Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
FARON.HE Faron Pharmaceuticals Oy
2.0700
-1.66%
HRTIS.HE Herantis Pharma Oyj
1.5800
0.00%
NYKD.OL Nykode Therapeutics AS
2.7640
+5.09%
ISOFOL.ST Isofol Medical AB (publ)
2.1100
-0.24%
BSLN.SW Basilea Pharmaceutica AG
40.55
+0.75%
VICO.ST Vicore Pharma Holding AB (publ)
9.20
+0.44%
SEER Seer, Inc.
2.3600
+1.29%
NANO.PA Nanobiotix S.A.
3.4800
+1.52%
XBIT XBiotech Inc.
3.6200
+0.28%
ADAG Adagene Inc.
1.8500
+1.65%